In particular, FOXC1 is a prognostic biomarker for BLBC [24, 26, 27], which is a form of triple-negative breast cancer for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.